Amgen
IMLYGIC
Manufacturer:
Amgen
Name:
IMLYGIC
Category:
J Code
HCPCS:
J9325
NDC(s):
55513-0078-01, 55513-0079-01,
Primary Type:
Cancer
Route of Administration:
Injection
About:
IMLYGIC is a Cancer drug manufactured by Amgen and administered via the Injection route of administration. The J Code: J9325 is aligned to the drug IMLYGIC.